ZNF788P: A Potential Drug Target and Biomarker (G388507)

ZNF788P: A Potential Drug Target and Biomarker

Introduction

Zinc finger genes (ZFGs) are a family of non-coding RNAs that play a crucial role in gene regulation and development. ZNF788P, a pseudogene and transcript variant 3, is one of the ZFGs that has garnered significant interest due to its unique function and potential involvement in various diseases. This article will provide an overview of ZNF788P, including its structure, function, and potential as a drug target or biomarker.

Structure and Function

ZNF788P is a member of the Zinc finger gene family, which is characterized by the presence of a conserved ZNF motif and the fusion of a nucleotide-binding oligomerization domain (NBO domain) and a zinc finger domain. The ZNF788P gene encodes a protein that contains a N-terminal ZNF motif, a middle conserved domain, and a C-terminal TAD-like domain.

Functional analysis of ZNF788P has shown that it plays a critical role in cell proliferation, survival, and angiogenesis. ZNF788P has been shown to be involved in various cellular processes, including cell growth, apoptosis, and cell-cell adhesion.

Additionally, ZNF788P has been shown to play a role in the regulation of cellular angiogenesis, which is the process by which new blood vessels form in the body. ZNF788P has been shown to be involved in the formation of blood vessels and the regulation of angiogenesis- related genes.

Potential as a Drug Target

The potential drug targets for ZNF788P include cancer, neurodegenerative diseases, and autoimmune diseases. ZNF788P has been shown to be involved in the regulation of various cellular processes that are critical for disease development, including cell proliferation, apoptosis, and angiogenesis. Therefore, targeting ZNF788P with small molecules or other therapeutic agents may be an effective way to treat diseases that are characterized by these processes.

ZNF788P has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in various cellular processes, including cell growth, apoptosis, and angiogenesis. Therefore, targeting ZNF788P with small molecules or Other therapeutic agents that can inhibit TGF-β signaling may be an effective way to treat diseases that are characterized by this pathway.

Potential as a Biomarker

The potential use of ZNF788P as a biomarker for disease diagnosis and monitoring has also been explored. ZNF788P has been shown to be expressed in various tissues and cells, including cancer cells, neurodegenerative cells, and blood vessels. Therefore, using ZNF788P as a biomarker for disease diagnosis and monitoring may be an effective way to identify and monitor disease progression.

Conclusion

ZNF788P is a pseudogene and transcript variant 3 that is characterized by its unique structure and function. ZNF788P has been shown to play a critical role in various cellular processes, including cell growth, apoptosis, and angiogenesis. The potential drug targets for ZNF788P include cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, ZNF788P has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. The potential use of ZNF788P as a biomarker for disease diagnosis and monitoring has also been explored . Further research is needed to fully understand the role of ZNF788P in disease and to develop effective treatments.

Protein Name: Zinc Finger Family Member 788, Pseudogene

The "ZNF788P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF788P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1 | ZRANB2 | ZRANB2-AS1